Heart Risks From Pain Pills Reviewed by FDA
- 10 years ago
The health risks of common pain killers called non-steroidal anti-inflammatory drugs, or NSAIDs, are being reassessed by the United States Food and Drug Administration.
The health risks of common pain killers called non-steroidal anti-inflammatory drugs, or NSAIDs, are being reassessed by the United States Food and Drug Administration.
Health risks from taking naproxen, the active ingredient in Bayer’s Aleve, were compared to other common over the counter pain killers like ibuprofen, which is sold under the brand name Advil and Motrin.
The FDA’s panel of experts reviewed an analysis from last year that looked at the results of over 700 studies involving the use of NSAIDs with around 350 thousand subjects.
The Food and Drug Administration has required NSAIDs to be labeled with possible health risks since 2005.
Victoria Richards, an assistant professor of medical sciences at the Frank H. Netter MD School of Medicine at Quinnipiac University in Connecticut is quoted as saying: “Research suggests that naproxen has a significantly lower risk of cardiovascular events than ibuprofen, although the dose of ibuprofen may be taken into consideration. This lower risk might be seen with low-dose ibuprofen.”
In the US, consumers reportedly purchased over 275 million boxes of over the counter pain killers which amounts to about 1 point 7 billion dollars in sales, while prescription NSAIDs like Celebrex reportedly had sales of 2 point 9 billion dollars.
The health risks of common pain killers called non-steroidal anti-inflammatory drugs, or NSAIDs, are being reassessed by the United States Food and Drug Administration.
Health risks from taking naproxen, the active ingredient in Bayer’s Aleve, were compared to other common over the counter pain killers like ibuprofen, which is sold under the brand name Advil and Motrin.
The FDA’s panel of experts reviewed an analysis from last year that looked at the results of over 700 studies involving the use of NSAIDs with around 350 thousand subjects.
The Food and Drug Administration has required NSAIDs to be labeled with possible health risks since 2005.
Victoria Richards, an assistant professor of medical sciences at the Frank H. Netter MD School of Medicine at Quinnipiac University in Connecticut is quoted as saying: “Research suggests that naproxen has a significantly lower risk of cardiovascular events than ibuprofen, although the dose of ibuprofen may be taken into consideration. This lower risk might be seen with low-dose ibuprofen.”
In the US, consumers reportedly purchased over 275 million boxes of over the counter pain killers which amounts to about 1 point 7 billion dollars in sales, while prescription NSAIDs like Celebrex reportedly had sales of 2 point 9 billion dollars.